Nascent Biotech Receives Clearance from FDA to Begin Phase I Human Trials in Brain Cancer
Vero Beach, FL December 10, 2018 – Nascent Biotech, Inc. (OTC: NBIO) Received US Food and Drug Administration (FDA) Clearance to begin Phase 1 Clinical Trials effective December 7th, 2018. [...]